Nerve test predicts treatment response in anti-MAG neuropathy
Part of Brain & nervous system clinical trials.
This study looks at whether a nerve test result can predict how well patients with anti-MAG neuropathy respond to treatment. It aims to help doctors choose the best therapy for each person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have anti-MAG neuropathy, confirmed by a positive blood test for anti-MAG antibodies and an IgM monoclonal gammopathy.
- You have had a nerve test (electroneuromyography) that shows clear results in at least two of these nerves: right median, ulnar, or common fibular.
- You have started treatment for your neuropathy, such as intravenous immunoglobulins (IVIg), rituximab, immunochemotherapy, BTK inhibitors, or symptomatic treatment.
- Your doctor has recorded your disability score (INCAT) before starting treatment and again 12 months later.
- You agree to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a specific type of light therapy (photobiomodulation) can improve symptoms of nerve damage (peripheral neuropathy) caused by anti-MAG antibodies. If you have this condition, this trial might offer a new way to manage your symptoms.
This Phase 3 study tests rituximab, an antibody medicine, for people with a particular type of nerve damage called anti-MAG–related demyelinating polyneuropathy. It aims to see if rituximab improves symptoms or function in patients who are considered “good responders.”
This study looks at how nerves work and their structure in people with Charcot-Marie-Tooth disease, CIDP, or anti-MAG neuropathy. It may help doctors better understand these conditions.
This study is testing a new gene-silencing treatment called NTLA-2001 for people with hereditary ATTR amyloidosis that causes nerve damage. It works by stopping the body from making a faulty protein that builds up and harms nerves.
This study uses MRI scans to look at nerve and muscle changes over time in people with inherited or acquired nerve conditions. It may help doctors better understand how these diseases progress.
This study looks at how well a nerve test result (the ratio of two nerve signals) can help tell apart types of peripheral neuropathy, and whether age affects that test's accuracy. It uses information from patients already evaluated at a specialized center.
Hear when a new Anti-MAG Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.